Galderma Group AG (GDERF)
OTCMKTS · Delayed Price · Currency is USD
191.00
+7.05 (3.83%)
Oct 31, 2025, 4:00 PM EDT
Galderma Group AG Market Cap
Galderma Group AG has a market cap or net worth of $43.89 billion as of October 31, 2025. Its market cap has increased by 96.60% in one year.
Market Cap
43.89B
Enterprise Value
46.26B
Revenue
4.69B
Ranking
n/a
PE Ratio
116.11
Stock Price
$191.00
Market Cap Chart
Since March 22, 2024, Galderma Group AG's market cap has increased from 16.92B to 43.89B, an increase of 159.36%. That is a compound annual growth rate of 80.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 43.68B | 65.71% |
| Dec 30, 2024 | 26.36B | 55.77% |
| Mar 22, 2024 | 16.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 648.67M |
| Glass House Brands | 563.30M |
| Northwest Biotherapeutics | 366.55M |
| Silence Therapeutics | 341.50M |
| Nika Pharmaceuticals | 312.10M |
| CytoDyn | 302.34M |
| American Oncology Network | 297.14M |